Click here to view the Blue Cross Blue Shield Tennessee Draft Medical Policies » April 2018 Draft Medical Policies: Tildrakizumab-asmn Pertuzumab Sildenafil Voretigene Neparvovec-rzyl Treprostinil for Continuous Subcutaneous Intravenous Infusion…
Click here to view the Blue Cross Blue Shield Tennessee Draft Medical Policies » March 2018 Draft Medical Policies: Avelumab Ado-Trastuzumab Emtansine Histrelin Acetate for Central Precocious Puberty (CPP) Bortezomib…
Click here to view the Blue Cross Blue Shield Tennessee Draft Medical Policies » February 2018 Draft Medical Policies: Transcatheter Hepatic Arterial Chemoembolization Expanded Molecular Panel Testing of Cancers to…
Click here to view the Blue Cross Blue Shield Tennessee Draft Medical Policies » January 2018 Draft Medical Policies: Serum Tumor Markers for Breast Malignancies Bendeka Carfilzomib Treanda Durvalumab Trabectedin…
Click here to view the Blue Cross Blue Shield Tennessee November 2017 Draft Medical Policies » November 2017 Draft Medical Policies: Tracking Number Medical Policy Name Beginning of Comment…
Click here to view the Blue Cross Blue Shield Tennessee November 2017 Pending Medical Policies » November 2017 Pending Medical Policies: Topics due to be included in the Medical Policy…
Click here to view the Blue Cross Blue Shield Tennessee Draft Medical Policies » November 2017 Draft Medical Policies: Tracking Number Medical Policy Name Beginning of Comment Period End of…
Blue Cross Blue Shield Tennessee posts July 2017 Draft Medical Policies available for comment: Blue Cross Blue Shield Tennessee July 2017 Draft Medical Policies Click here to view the Blue…
